Cholangiocarcinoma: New insights

dc.authorid0000-0002-2197-0466
dc.contributor.authorGöral, Vedat
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:36:24Z
dc.date.available10.07.201910:49:14
dc.date.available2019-07-10T19:36:24Z
dc.date.issued2017
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstractCholangiocarcinoma is a malignant neoplasm originating from biliary epithelial cells. The incidence and mortality of this cancer are rising in the world. Currently, cholangiocarcinoma is accepted as a stem cell disease with many risk factors. Diagnosis is relatively simple but therapy is extremely difficult. Surgery is the mainstay of treatment for early stage patients. Endobiliary approaches, chemotherapy and radiotherapy are other therapeutic approaches.
dc.identifier.citationGöral, V. (2017). Cholangiocarcinoma: New insights. Asian Pacific Journal of Cancer Prevention, 18(6), 1469-1473. https://dx.doi.org/10.22034/APJCP.2017.18.6.1469
dc.identifier.doi10.22034/APJCP.2017.18.6.1469
dc.identifier.endpage1473
dc.identifier.issn1513-7368
dc.identifier.issue6
dc.identifier.scopusqualityQ2
dc.identifier.startpage1469
dc.identifier.urihttps://hdl.handle.net/20.500.12511/1154
dc.identifier.urihttps://dx.doi.org/10.22034/APJCP.2017.18.6.1469
dc.identifier.volume18
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAsian Pacific Organization for Cancer Prevention
dc.relation.ispartofAsian Pacific Journal of Cancer Preventionen_US
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCholangiocarcinoma
dc.subjectPathogenesis
dc.subjectStem Cell Disease
dc.titleCholangiocarcinoma: New insights
dc.typeOther

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
goral-vedat(2017).pdf
Boyut:
830.59 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text